Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/16/12 → 10/30/16 |
IMUNITI A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Diseas
- Selby, Lisbeth (PI)
- De Villiers, Willem (Former PI)